RE:lmnl is about to double its market cap with the deal We get that you're desperately trying to get your money out. How does cash help them other than to stay at the current price level? There is no long term clinical possibility here or they would have had it on their slides as the next trial. They chose IPF and tryglycer..... and that failed. What about liver and kidney? They determined that these were not good enough. Either that or they are perpetuating another fraud to release all bad news and go private to sell 4050. They are not communicating clearly on purpose. Personally, I think 4050 IP will be sold privately - probably for liver (alstrom results were amazing) and kidney.
realstocky wrote:
they signed with kedrion (worth 100M$) for the priority voucher... piper price target is a joke, camo is right. Why didnt they wait on the FDA decision and put out a proper price targer...clowns...sharks... pick one:)
What is their price target? 4.50$? what happens if we get the FDA ok next days? 10$?
clowns:)